Lipella Pharmaceuticals (LIPO)

• Market cap: $3.16M
• 1 day: 1.56%
• 5 days: 1.56%
• 1 month: 8.30%
• 3 months: -21.39%
• 6 months: -49.32%
• Year to date: -65.34%
• 1 year: -67.38%
• 5 years: -93.07%
• 10 years: -93.07%
• Sector: Healthcare
• Industry: Pharmaceutical Preparations

About: Lipella Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. The company's product candidates include LP-10, LP-310 and LP-410 which can be helpful in treatment of Hemorrahagic Cystitis, Oral Licen Planus and Oral Graft.

Employees: 7

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

7.22% less ownership

Funds ownership: 8.28% [Q2] → 1.06% (-7.22%) [Q3]

29% less funds holding

Funds holding: 7 [Q2] → 5 (-2) [Q3]

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

86% less capital invested

Capital invested by funds: $284K [Q2] → $39.7K (-$244K) [Q3]

100% less funds holding in top 10

Funds holding in top 10: 1 [Q2] → 0 (-1) [Q3]